| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Property and equipment, net | 382,806 | |||
| Cash, restricted cash, and cash equivalents | 3,302,674 | |||
| Prepaid expenses and other current assets | 443,892 | |||
| Investment in equity securities, at cost | 500,000 | |||
| Deferred offering costs | 0 | |||
| Total current assets | 4,246,566 | |||
| Operating lease right-of-use assets | 1,072,950 | |||
| Deferred offering costs, net of current portion | 500,000 | |||
| Total assets | 6,202,322 | |||
| Accrued liabilities | 365,060 | |||
| Operating lease liability | 934,310 | |||
| Accounts payable | 6,213,045 | |||
| Earnout liability | 20,000 | |||
| Deemed dividend common stock liability, 692 shares | 85,500 | |||
| Total current liabilities | 7,617,915 | |||
| Operating lease liability, net of current portion | 218,308 | |||
| Total liabilities | 7,836,223 | |||
| Stock subscription receivable | 78,750 | |||
| Accumulated deficit | -81,441,099 | |||
| Convertible preferred stock, value-Series DConvertible Preferred Stock | 7,240,180 | |||
| Convertible preferred stock, value-Series CConvertible Preferred Stock | 46,935 | |||
| Convertible preferred stock, value-Series BConvertible Preferred Stock | 0 | |||
| Convertible preferred stock, value-Series AConvertible Preferred Stock | 1,287,315 | |||
| Common stock, value-Common Class A | 119 | |||
| Additional paid-in capital | 71,311,399 | |||
| Total stockholders deficit | -1,633,901 | |||
| Total liabilities and stockholders deficit | 6,202,322 | |||
CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CERO THERAPEUTICS HOLDINGS, INC. (CERO)